While we haven’t quite achieved the level of truly personalised medicine yet, cell and gene therapy come fairly close.
Viralgen chief executive officer Jimmy Vanhove notes that there have been three important waves of innovation in the pharmaceutical space to date: small molecules, large molecules and targeted therapies, and now, cell and gene therapy.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
